Zhejiang Sunflower Light Energy Asset Resilience Ratio
Zhejiang Sunflower Light Energy asset resilience ratio. Zhejiang Sunflower Light Energy (300111) has an Asset Resilience Ratio of 9.30% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how many days can Zhejiang Sunflower Light Energy fund operations to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Zhejiang Sunflower Light Energy (2008–2022)
Asset resilience ratio of Zhejiang Sunflower Light Energy from 2008 to 2022. This chart shows how Zhejiang Sunflower Light Energy's Asset Resilience Ratio has changed over time. Read how much debt does Zhejiang Sunflower Light Energy carry for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Zhejiang Sunflower Light Energy's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see 300111 total asset value.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥90.07 Million | 9.3% |
| Total Liquid Assets | CN¥90.07 Million | 9.30% |
Asset Resilience Insights
- Limited Liquidity: Zhejiang Sunflower Light Energy maintains only 9.30% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Zhejiang Sunflower Light Energy Industry Peers by Asset Resilience Ratio
Compare Zhejiang Sunflower Light Energy's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Jiangsu Nhwa Pharmaceutical Co Ltd
SHE:002262 |
Drug Manufacturers - Specialty & Generic | 26.45% |
|
Tibet Rhodiola Pharmaceutical Holding Co
SHG:600211 |
Drug Manufacturers - Specialty & Generic | 11.84% |
|
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091 |
Drug Manufacturers - Specialty & Generic | 26.36% |
|
Renhe Pharmacy Co Ltd
SHE:000650 |
Drug Manufacturers - Specialty & Generic | 37.54% |
|
Bide Pharmatech Co. Ltd. A
SHG:688073 |
Drug Manufacturers - Specialty & Generic | 9.46% |
|
Jianmin Pharmaceutical Group Co Ltd
SHG:600976 |
Drug Manufacturers - Specialty & Generic | 20.61% |
|
Qianjiang Yongan Pharmaceutical Co Ltd
SHE:002365 |
Drug Manufacturers - Specialty & Generic | 30.38% |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078 |
Drug Manufacturers - Specialty & Generic | 0.42% |
Zhejiang Sunflower Light Energy Asset Resilience Ratio by Year (2008–2022)
Zhejiang Sunflower Light Energy asset resilience ratio by year from 2008 to 2022. The table below shows the annual Asset Resilience Ratio data for Zhejiang Sunflower Light Energy.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2022-12-31 | -0.12% | CN¥-723.79K ≈ $-105.91K |
CN¥616.25 Million ≈ $90.18 Million |
-0.12pp |
| 2021-12-31 | 0.00% | CN¥2.00K ≈ $292.66 |
CN¥631.63 Million ≈ $92.43 Million |
+0.23pp |
| 2020-12-31 | -0.23% | CN¥-1.28 Million ≈ $-187.15K |
CN¥564.44 Million ≈ $82.60 Million |
+0.22pp |
| 2019-12-31 | -0.45% | CN¥-3.11 Million ≈ $-454.84K |
CN¥694.03 Million ≈ $101.56 Million |
+0.14pp |
| 2018-12-31 | -0.58% | CN¥-8.50 Million ≈ $-1.24 Million |
CN¥1.46 Billion ≈ $213.11 Million |
-1.41pp |
| 2012-12-31 | 0.83% | CN¥25.09 Million ≈ $3.67 Million |
CN¥3.04 Billion ≈ $444.47 Million |
-2.45pp |
| 2011-12-31 | 3.28% | CN¥116.41 Million ≈ $17.03 Million |
CN¥3.55 Billion ≈ $519.44 Million |
+0.53pp |
| 2010-12-31 | 2.75% | CN¥77.40 Million ≈ $11.33 Million |
CN¥2.81 Billion ≈ $411.37 Million |
+1.51pp |
| 2008-12-31 | 1.25% | CN¥20.00 Million ≈ $2.93 Million |
CN¥1.60 Billion ≈ $234.81 Million |
-- |
About Zhejiang Sunflower Light Energy
Zhejiang Sunflower Great Health Co., Ltd. engages in the research, development, production, and sale of anti-infectious, cardiovascular, digestive system and other drugs in China and internationally. It offers clarithromycin API and tablets, anti-infective drugs used for nasopharyngeal infection, lower respiratory tract infection, skin and soft tissue infection, acute otitis media, Mycoplasma pne… Read more